Holen Sie sich die Stockscreener-App
63.76
2.12%
-1.38
Handel nachbörslich:
63.87
0.11
+0.17%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$65.14
Offen:
$65.34
24-Stunden-Volumen:
13.84M
Relative Volume:
1.07
Marktkapitalisierung:
$87.11B
Einnahmen:
$16.21B
Nettoeinkommen (Verlust:
$4.29B
KGV:
19.37
EPS:
3.292
Netto-Cashflow:
$4.05B
1W Leistung:
-4.02%
1M Leistung:
-18.58%
6M Leistung:
-12.82%
1J Leistung:
-30.11%
1-Tages-Spanne:
$63.48
$65.38
1-Wochen-Bereich:
$62.95
$69.54
52-Wochen-Spanne:
$56.32
$113.00
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Vergleichen Sie LRCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
63.76 | 87.11B | 16.21B | 4.29B | 4.05B | 3.292 |
|
ASML
Asml Holding Nv
|
640.16 | 264.57B | 30.55B | 8.18B | 9.83B | 20.79 |
|
AMAT
Applied Materials Inc
|
137.46 | 117.42B | 27.64B | 6.34B | 5.94B | 7.65 |
|
KLAC
Kla Corp
|
634.43 | 89.03B | 10.85B | 3.21B | 3.36B | 23.78 |
|
TER
Teradyne Inc
|
71.25 | 11.88B | 2.74B | 513.17M | 453.35M | 3.15 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Qtron Investments LLC Acquires 21,589 Shares of Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Sterling Capital Management LLC Boosts Stock Position in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Stifel Nicolaus Issues Pessimistic Forecast for Lam Research (NASDAQ:LRCX) Stock Price - MarketBeat
Lam Research Corporation (LRCX): Among Louis Navellier’s New Stock Picks - Insider Monkey
Rep. Jefferson Shreve Sells Off Shares of Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Lam Research: Tides Have Turned, Buy This Semiconductor Refurbisher (NASDAQ:LRCX) - Seeking Alpha
Kane Investment Management Inc. Makes New Investment in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Rench Wealth Management Inc. Boosts Stake in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Lam Research Co. (NASDAQ:LRCX) Shares Acquired by Bridgewater Associates LP - MarketBeat
Lam Research Co. (NASDAQ:LRCX) Shares Acquired by Guggenheim Capital LLC - MarketBeat
Canada Post Corp Registered Pension Plan Purchases Shares of 21,890 Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Mariner LLC Buys 835,135 Shares of Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Advisors Capital Management LLC Takes Position in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Texas Capital Bancshares Inc TX Grows Stock Position in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Oak Associates Ltd. OH Raises Position in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Lam Research Co. (NASDAQ:LRCX) Stock Position Increased by Phoenix Financial Ltd. - MarketBeat
Lam Research (LRCX) to Release Quarterly Earnings on Wednesday - MarketBeat
UBS Group Cuts Lam Research (NASDAQ:LRCX) Price Target to $90.00 - MarketBeat
These Semiconductor Stocks To Face Least Tariffs Impact Compared To Intel - Benzinga
Lam Research Corp. stock outperforms competitors despite losses on the day - MarketWatch
BofA Securities Adjusts Lam Research Price Target to $90 From $110, Maintains Buy Rating - MarketScreener
Applied Materials, Lam Research, KLA Drop Amid Fresh Trade War Fears, Revenue Risk - Benzinga
Lam Research (LRCX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Analyst Expectations For Lam Research's Future - Benzinga
Revolutionary Chip Technology: Lam Research Supercharges UC Berkeley's Semiconductor Research - Stock Titan
Keystone Financial Group Acquires 5,396 Shares of Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Summit Investment Advisors Inc. Grows Position in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Argent Trust Co Increases Stock Position in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Oppenheimer Lowers Lam Research (NASDAQ:LRCX) Price Target to $80.00 - MarketBeat
Lam Research (NASDAQ:LRCX) Shares Acquired Rep. Jefferson Shreve - MarketBeat
Heritage Trust Co Takes Position in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Legacy Financial Advisors Inc. Raises Stake in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
First Foundation Advisors Acquires 18,130 Shares of Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Stifel Nicolaus Adjusts Lam Research Price Target to $92 From $100, Maintains Buy Rating - MarketScreener
Lam Research Corp (LRCX)'s Winning Formula: Financial Metrics and Competitive Strengths - GuruFocus
Stifel Adjusts Lam Research (LRCX) Price Target Amid Industry Sh - GuruFocus
Brokers Suggest Investing in Lam Research (LRCX): Read This Before Placing a Bet - Yahoo Finance
Menora Mivtachim Holdings LTD. Invests $99.78 Million in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
10,292 Shares in Lam Research Co. (NASDAQ:LRCX) Acquired by 3Chopt Investment Partners LLC - MarketBeat
Lam Research Co. (NASDAQ:LRCX) Shares Purchased by Primoris Wealth Advisors LLC - MarketBeat
Altman Advisors Inc. Acquires New Shares in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Seeds Investor LLC Has $647,000 Stake in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Scotia Capital Inc. Grows Position in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
7 Chipmaker Stocks Set To Gain As Trump Delays Tariff Blow On Key China Tech Imports: Bank Of America - Benzinga
UBS Adjusts Price Target for Lam Research (LRCX) Ahead of Earnin - GuruFocus
UBS Adjusts Lam Research Price Target to $90 From $95, Maintains Buy Rating - MarketScreener
Cim Investment Management Inc. Has $712,000 Holdings in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Nicolet Bankshares Inc. Acquires 8,775 Shares of Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Ceeto Capital Group LLC Boosts Stock Holdings in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Lam Research Co. (NASDAQ:LRCX) Shares Bought by Bessemer Group Inc. - MarketBeat
Winslow Capital Management LLC Raises Holdings in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.21%
0.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):